- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Leiden University Medical Center](/img/noimage_org.png)
Leiden University Medical Center
Leiden, HolandaPublications en collaboration avec des chercheurs de Leiden University Medical Center (8)
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
The Aging Imageomics Study: rationale, design and baseline characteristics of the study population
Mechanisms of Ageing and Development, Vol. 189
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
2014
-
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
Molecular Cancer, Vol. 13, Núm. 1
2011
2007
-
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents
Journal of Medical Genetics, Vol. 44, Núm. 2, pp. 99-106
2006
-
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Cancer Research, Vol. 66, Núm. 20, pp. 9818-9828